EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Mixed-Methods-StudieOpen Access · CC BY-NC 4.0

Subcutaneous Infusion of Benzathine Penicillin G Is Acceptable and Preferred Over Intramuscular Injections for Syphilis in Western Australian Sexual Health Clinic Attendees: A Mixed Methods Sub-study

Shakayla L Walley iD, Jane Oliver iD, Stephanie L Enkel iD, Alice Kupara, Simon Swallow, Joseph Cotter iD, Gerard F Hoyne iD, Thel K Hla iD, Laurens Manning iD

The Patient - Patient-Centered Outcomes Research · 2026

DOI: 10.1007/s40271-025-00764-4 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift The Patient - Patient-Centered Outcomes Research, 2026. Verfasst von Shakayla L Walley und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences, University of Notre Dame Australia, Fremantle, WA, Australia. Hauptthemen laut MEDLINE: Penicillin G Benzathine, Syphilis, Anti-Bacterial Agents, Patient Preference. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Department of Health Sexually Transmitted Infections and Blood Borne Viruses Research Program, Medical Research Future Fund Emerging Leadership 2 Fellowship, University of Western Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Controlling the syphilis epidemic in Australia is a public health priority. Regular intramuscular (IM) injections of benzathine penicillin G (BPG) are the current standard of care for late latent syphilis in Australia; however, repeated IM BPG injections are painful, and treatment completion rates are low. Early-phase clinical trials have demonstrated the tolerability and safety of high-dose subcutaneous infusions of BPG (SCIP), where the total treatment dose can be delivered at a single visit. Here we describe the experiences and preferences of attendees of Western Australian sexual health clinics in the Perth metropolitan region who have syphilis and were treated with SCIP. METHODS: This was a mixed methods sub-study of a phase IIa clinical trial (ACTRN12622000349741). Eligible participants attended South Terrace Sexual Health Clinic in Fremantle, Western Australia, after referral from physicians to the South Metropolitan Health Service. Nine participants were followed up with for 24 weeks after receiving SCIP. Semi-structured interviews were conducted at three time points. All interviews were audio recorded, transcribed verbatim and underwent content and thematic analyses. RESULTS: Two themes were identified: (1) tolerance of SCIP and (2) SCIP is preferred over IM BPG. SCIP was well-tolerated by participants, who praised the ease and convenience of the procedure. Participants described instances of mild to moderate pain during and after SCIP, substantiated by self-reported pain scores and adapted Skindex-16 scores. All participants stated that they would prefer SCIP over IM BPG as syphilis treatment, and that they would be willing to receive SCIP again should re-infection occur. CONCLUSION: All participants described tolerable infusion experiences with a clear preference for SCIP over IM BPG to treat syphilis. SCIP has potential to replace IM BPG in clinical practice. Further research is needed to determine the acceptability and efficacy of SCIP in diverse cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Penicillin G BenzathineSyphilisAnti-Bacterial AgentsPatient PreferenceHumansMaleInjections, IntramuscularAdultFemaleMiddle AgedWestern AustraliaInjections, Subcutaneous

Substanzen

Penicillin G BenzathineAnti-Bacterial Agents

Autor:innen und Institutionen

  • School of Health Sciences, University of Notre Dame Australia, Fremantle, WA, Australia.
  • Wesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute Australia, Nedlands, WA, Australia.
  • Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
  • Centre for Child Health Research, University of Western Australia, Crawley, WA, Australia.
  • Medical School, University of Western Australia, Crawley, WA, Australia.
  • South Terrace Clinic, Fremantle Hospital, Fremantle, WA, Australia.

ORCID-Profile: Shakayla L Walley, Jane Oliver, Stephanie L Enkel, Joseph Cotter, Gerard F Hoyne, Thel K Hla, Laurens Manning

Förderung

  • Department of Health Sexually Transmitted Infections and Blood Borne Viruses Research Program
  • Medical Research Future Fund Emerging Leadership 2 Fellowship
  • University of Western Australia

Zitieren

APA

Walley, S. L., Oliver, J., Enkel, S. L., Kupara, A., Swallow, S., Cotter, J., Hoyne, G. F., Hla, T. K., & Manning, L. (2026). Subcutaneous Infusion of Benzathine Penicillin G Is Acceptable and Preferred Over Intramuscular Injections for Syphilis in Western Australian Sexual Health Clinic Attendees: A Mixed Methods Sub-study. The Patient - Patient-Centered Outcomes Research. https://doi.org/10.1007/s40271-025-00764-4

Vancouver

Walley SL, Oliver J, Enkel SL, Kupara A, Swallow S, Cotter J, et al. Subcutaneous Infusion of Benzathine Penicillin G Is Acceptable and Preferred Over Intramuscular Injections for Syphilis in Western Australian Sexual Health Clinic Attendees: A Mixed Methods Sub-study. The Patient - Patient-Centered Outcomes Research. 2026. doi:10.1007/s40271-025-00764-4

BibTeX
@article{Walley2026,
  author = {Walley, Shakayla L and Oliver, Jane and Enkel, Stephanie L and Kupara, Alice and Swallow, Simon and Cotter, Joseph and Hoyne, Gerard F and Hla, Thel K and Manning, Laurens},
  title = {Subcutaneous Infusion of Benzathine Penicillin G Is Acceptable and Preferred Over Intramuscular Injections for Syphilis in Western Australian Sexual Health Clinic Attendees: A Mixed Methods Sub-study},
  journal = {The Patient - Patient-Centered Outcomes Research},
  year = {2026},
  doi = {10.1007/s40271-025-00764-4}
}
Kostenlos starten →